Paired cerebrospinal fluid and serum samples of patients with amyotrophic lateral sclerosis (n = 35) revealed no consistent abnormalities of CSF cell count,
The results of CSF and serum ganglioside antibody determination in amyotrophic lateral sclerosis and the incidence of pathological normalised optical density readings in these patients are provided in tables 1 and 2. The controls with other neurological diseases were not different from the internal controls. CSF IgG, but not age or gender, had an influence on ganglioside antibodies in those with other neurological diseases, before adjustment. The Pearson coefficients were 014 (GM1), 0-56 (GM2), 037 (GM3), 0-23 (AGMI), 0-48 (GDla), 0 47 (GDlb) and 0 35 (GTIb). Among the seven ganglioside antibodies examined, there was considerable intercorrelation in the amyotrophic lateral sclerosis samples (Pearson coefficient 0 3-0-6), suggesting that most of the sera contain either antibodies with multiple ganglioside reactivity or multiple antibodies against different gangliosides, a suggestion that was confirmed by twin layer chromatography. The degree of normalised optical density elevation among the patients with the disease was fairly heterogeneous (figs 1 and 2). The two patients with CSF oligoclonal bands did not differ in their ganglioside CSF IgM to all gangliosides except AGMI was elevated in the patients compared with those with other neurological diseases. CSF IgM to GM2, GM3, GD1a, GD1b, and GTIb was also higher than in chronic progressive multiple sclerosis. On the other hand, patients with chronic progressive multiple sclerosis had higher CSF IgG optical density readings to GM2, GM3, GD 1 a, and GDlb than patients with amyotrophic lateral sclerosis. CSF IgG antibodies to GM2, GM3, GDla, and GDlb, as well as IgM antibodies to GDla, GDlb, and GTlb were lower than in relapsing remitting multiple sclerosis. There was no correlation between CSF or serum ganglioside antibodies in amyotrophic lateral or multiple sclerosis.
Discriminant analysis performed on normalised CSF optical density readings to all seven gangliosides allowed correct reclassification of 75% of the patients with the disease. When variables were selected by stepwise entry depending on Wilk's ). reduction, the same classification results were obtained using IgG antibodies to GM2 and GM3, which are low in amyotrophic lateral sclerosis, in association with IgM antibodies to GDla and GDlb, which are high. None of the controls and 3% of the patients with multiple sclerosis were falsely classified as having amyotrophic lateral sclerosis.
The The lack of elevation of total CSF IgM or the IgM index appears to prove that the immune activation detected in this study cannot be very strong. Nevertheless, we have identified a phenomenon which distinguishes amyotrophic lateral sclerosis from other neurological diseases and normal controls which warrants further investigation. Rather than claiming a primary pathogenetic role of ganglioside antibodies, we suggest that our findings may be related to an alteration of the ganglioside composition in the brain28 and spinal cord29 of patients with the disease.
